Who can use Vyloy(zolbetuximab)?
Zolbetuximab is indicated for the treatment of Claudin 18.2 (CLDN18.2)-positive, unresectable advanced or recurrent gastric cancer.
Zolbetuximab is an injection (colorless vial): 100mg per vial.
zolbetuximab(Vyloy)
VYLOY is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or...
CATEGORY NAVIGATION
RELATED ARTICLES
Instructions for zotuximab (zolbetuximab)
Zolbetuximab has demonstrated significant therapeutic potential in the treatment of malignant tumors such as gastric...
Monday, September 1st, 2025, 14:15
Zolbetuximab: Indications, Dosage and Administration, and Precautions
Zolbetuximab has demonstrated significant therapeutic potential in the treatment of malignant tumors such as gastric...
Monday, September 1st, 2025, 13:57
Zolbetuximab: Clinical Uses, Recommended Dosage, Potential Side Effects
Zolbetuximab (brand name: VYLOY) is a cytolytic antibody targeting Claudin 18.2 (CLDN18.2). It was first approved...
Monday, September 1st, 2025, 11:51
1 / 1
3 in total
Departments
Contact Medical Consultant
Global Drug
Search
Clinical
recruitment
overseas
medical treatment
Remote
consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly
protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved